SCHEMBL15020123

SCHEMBL15020123

O=C(O)c1cc2cc(OCF)ccc2cn1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
PTPN7 P35236 1/20 0.41
P4HTM Q9NXG6 2/20 0.40
ASPH Q12797 3/20 0.39
KDM4E B2RXH2 2/20 0.39
KDM8 Q8N371 2/20 0.39
EGLN1 Q9GZT9 1/20 0.38
RIOX2 Q8IUF8 1/20 0.38
MRGPRX4 Q96LA9 2/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ABL1 P00519 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
CYSLTR1 Q9Y271 1/20 0.36
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
EGFR P00533 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6102490 0.85 AKR1C3 (0.51) MAPTP4HTMKDM4ENPC1RAB9A
SCHEMBL15019426 0.84 LCK (0.50) MAPTKDM4EABL1
SCHEMBL4243746 0.82 TSHR (0.47) MAPTKDM4ENPC1RAB9A
SCHEMBL1202394 0.81 KDM4E (0.56) P4HTMASPHKDM4EKDM8RIOX2
SCHEMBL4242693 0.81 P4HTM (0.65) MAPTP4HTMKDM4EMRGPRX4NPC1
SCHEMBL21200217 0.79 CBLB (0.48) PTPN7ASPHKDM4EKDM8RIOX2
SCHEMBL1202095 0.79 MCL1 (0.51) ABL1NR1H4
SCHEMBL21200444 0.77 PTPN7 (0.40) MAPTPTPN7ASPHKDM4EKDM8
SCHEMBL991920 0.77 P4HTM (0.63) MAPTP4HTMKDM4E
SCHEMBL1201238 0.77 P4HTM (0.67) MAPTP4HTMKDM4EMRGPRX4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2791130-A1 PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS Boehringer Ingelheim International GmbH (DE) 2014-10-22 EP disclosed
WO-2013087805-A1 PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 WO disclosed